Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

BUY
$159.82 - $182.1 $24.3 Million - $27.7 Million
152,158 New
152,158 $27.7 Million
Q2 2023

Aug 10, 2023

BUY
$132.51 - $164.9 $267,272 - $332,603
2,017 Added 1.39%
147,358 $19.9 Million
Q1 2023

May 15, 2023

SELL
$144.61 - $166.54 $94,719 - $109,083
-655 Reduced 0.45%
145,341 $23.2 Million
Q4 2022

Feb 14, 2023

SELL
$138.31 - $165.87 $583,391 - $699,639
-4,218 Reduced 2.81%
145,996 $23.6 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $523,284 - $600,173
3,899 Added 2.66%
150,214 $20.2 Million
Q2 2022

Aug 15, 2022

BUY
$137.62 - $174.96 $4,403 - $5,598
32 Added 0.02%
146,315 $22.4 Million
Q1 2022

May 11, 2022

BUY
$131.98 - $163.75 $19.3 Million - $24 Million
146,283 New
146,283 $23.7 Million
Q4 2021

Feb 15, 2022

SELL
$107.43 - $135.93 $15.4 Million - $19.5 Million
-143,483 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$106.4 - $120.78 $230,888 - $262,092
2,170 Added 1.54%
143,483 $15.5 Million
Q2 2021

Aug 13, 2021

SELL
$105.21 - $117.21 $224,623 - $250,243
-2,135 Reduced 1.49%
141,313 $15.9 Million
Q1 2021

May 14, 2021

BUY
$102.3 - $112.62 $120,611 - $132,778
1,179 Added 0.83%
143,448 $15.5 Million
Q4 2020

Feb 12, 2021

BUY
$80.49 - $108.67 $53,203 - $71,830
661 Added 0.47%
142,269 $15.2 Million
Q3 2020

Nov 16, 2020

SELL
$85.91 - $100.83 $88,659 - $104,056
-1,032 Reduced 0.72%
141,608 $12.4 Million
Q2 2020

Aug 13, 2020

BUY
$73.37 - $98.18 $10.5 Million - $14 Million
142,640 New
142,640 $14 Million
Q1 2020

May 20, 2020

SELL
$64.5 - $97.79 $9.02 Million - $13.7 Million
-139,824 Closed
0 $0
Q4 2019

Feb 13, 2020

SELL
$72.13 - $90.25 $146,496 - $183,297
-2,031 Reduced 1.43%
139,824 $12.4 Million
Q3 2019

Nov 14, 2019

SELL
$62.98 - $75.72 $89,494 - $107,598
-1,421 Reduced 0.99%
141,855 $10.7 Million
Q2 2019

Aug 14, 2019

SELL
$65.7 - $83.98 $7,555 - $9,657
-115 Reduced 0.08%
143,276 $10.4 Million
Q1 2019

May 13, 2019

BUY
$77.14 - $90.79 $115,864 - $136,366
1,502 Added 1.06%
143,391 $11.6 Million
Q4 2018

Feb 13, 2019

SELL
$77.85 - $96.01 $243,904 - $300,799
-3,133 Reduced 2.16%
141,889 $13.1 Million
Q3 2018

Nov 14, 2018

SELL
$88.91 - $98.84 $76,462 - $85,002
-860 Reduced 0.59%
145,022 $13.7 Million
Q2 2018

Aug 14, 2018

BUY
$89.78 - $106.23 $978,063 - $1.16 Million
10,894 Added 8.07%
145,882 $13.5 Million
Q1 2018

May 15, 2018

SELL
$92.01 - $123.21 $14,353 - $19,220
-156 Reduced 0.12%
134,988 $12.8 Million
Q4 2017

Feb 14, 2018

SELL
$89.56 - $98.21 $41,287 - $45,274
-461 Reduced 0.34%
135,144 $13.1 Million
Q3 2017

Nov 14, 2017

BUY
$69.85 - $89.22 $9.47 Million - $12.1 Million
135,605
135,605 $12 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Johnson Investment Counsel Inc Portfolio

Follow Johnson Investment Counsel Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Johnson Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Johnson Investment Counsel Inc with notifications on news.